Answers are grounded in this paper and cite their sources.
Pre-analytical errors such as sample mix-ups can compromise the integrity of pharmacokinetic (PK) data.We simulated vancomycin PK data and introduced two error types: intra-individual time point swap (TS) errors and inter-individual concentration swap (CS) errors.This study developed and validated two automated detection approaches-a run-test-based non-parametric method and a Mahalanobis distance-based method with leave-one-out cross-validation (LOOCV)-for identifying pre-analytical errors in PK datasets.Performance was evaluated using 12,500 simulated profiles comparing the two methods.The distance-based method demonstrated significantly higher error detection rate (79.7% vs. 59.6%, p < 0.001) and greater area under the receiver operating characteristic curve (0.856; 95% confidence interval [CI], 0.816-0.889vs. 0.574; 95% CI, 0.541-0.610)compared to the run-test, while maintaining reasonable specificity (76.4% vs. 84.0%).For TS errors, the distance-based method achieved higher recall (80.4% vs. 71.9%)and modestly higher F1-score (0.530 vs. 0.515).For CS errors, the distance-based method demonstrated superior precision (86.1% vs. 59.8%) with comparable F1-score (0.572 vs. 0.564).Detection was robust across alternative PopPK models, a structurally different drug (theophylline), training-set contamination (with the minimum covariance determinant estimator recommended for non-curated training), missing data (with sub-vector marginal handling), and samplingtime jitter.Overall, the distance-based method with LOOCV outperformed the conventional run-test across key performance metrics and can serve as a practical quality control tool for ensuring PK data integrity in clinical pharmacology research.
No takes yet. Share an insight, caveat, or question.
Shim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: